Emerging roles of checkpoint molecules on B cells
Immune checkpoint molecules, including both co-inhibitory molecules and co-stimulatory molecules, are known to play critical roles in regulating T-cell responses. During the last decades, immunotherapies targeting these molecules (such as programmed cell death 1 (PD-1), and lymphocyte activation gen...
Saved in:
Main Authors: | Hiromitsu Asashima, Satoshi Akao, Isao Matsumoto |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-01-01
|
Series: | Immunological Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/25785826.2025.2454045 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences in the intrahepatic expression of immune checkpoint molecules on T cells and natural killer cells in chronic HBV patients
by: Lucile Dumolard, et al.
Published: (2025-01-01) -
Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
by: Ziting Peng, et al.
Published: (2025-02-01) -
Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
by: Haiqing Zhao, et al.
Published: (2024-09-01) -
PD-L1 positive platelets mediate resistance to immune checkpoint inhibitors in patients with colorectal cancer
by: Jiacheng Li, et al.
Published: (2025-01-01) -
Breast Cancer Conditioned Media Modulate the Expression of Immune Checkpoints and Adhesion Molecules in Endothelial Cells
by: İpek Türkdönmez, et al.
Published: (2024-04-01)